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ess under CC BY-NC-Abstract Smart polymers have enormous potential in various applications. In particular, smart
polymeric drug delivery systems have been explored as “intelligent” delivery systems able to release,
at the appropriate time and site of action, entrapped drugs in response to speciﬁc physiological triggers.
These polymers exhibit a non-linear response to a small stimulus leading to a macroscopic alteration in
their structure/properties. The responses vary widely from swelling/contraction to disintegration. Synthesis
of new polymers and crosslinkers with greater biocompatibility and better biodegradability would increase
and enhance current applications. The most fascinating features of the smart polymers arise from their
versatility and tunable sensitivity. The most signiﬁcant weakness of all these external stimuli-sensitive
polymers is slow response time. The versatility of polymer sources and their combinatorial synthesis make
it possible to tune polymer sensitivity to a given stimulus within a narrow range. Development of smart
polymer systems may lead to more accurate and programmable drug delivery. In this review, we discuss
various mechanisms by which polymer systems are assembled in situ to form implanted devices for
sustained release of therapeutic macromolecules, and we highlight various applications in the ﬁeld of
advanced drug delivery.
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Polymers for the controlled delivery of drugs 1211. Introduction
Pharmaceutical and biological therapeutics are often limited by
short half-lives, poor bioavailability, and physical and chemical
instability. Physical instability mainly includes alteration of highly
ordered protein structure, leading to undesirable processes such as
denaturation, aggregation and precipitation. Reactions such as
oxidation, deamidation, hydrolysis and racemisation contribute to
the chemical instability of drugs. Stimuli-responsive polymers
offer a drug delivery platform that can be utilised to deliver drugs
at a controlled rate and in a stable and biologically active form.
Over many decades, interest in stimuli-responsive polymers has
increased and great deal of work has been committed to developing
environmentally sensitive macromolecules that can be moulded
into new smart polymers. Table 1 lists various stimuli and smart
polymers that can mediate such dramatic behaviour. Smart polymers
are becoming increasingly important in the ﬁelds of controlled drug
delivery, biomedical applications, and tissue engineering, and it is
often beneﬁcial to employ polymers that can respond to stimuliTable 1 Various stimuli and responsive materials.
Environmental stimulus Responsive material
Temperature Poloxamers
Poly(N-alkylacrylamide)s
Poly(N-vinylcaprolactam)s
Cellulose, xyloglucan
Chitosan
pH Poly(methacrylicacid)s
Poly(vinylpyridine)s
Poly(vinylimidazole)s
Light Modiﬁed poly(acrylamide)s
Electric ﬁeld Sulfonated polystyrenes
Poly(thiophene)s
Poly(ethyloxazoline)
Ultrasound Ethylenevinylacetate
Table 2 Various smart polymeric drug delivery systems.
Stimulus Advantage Limitation
Temperature Ease of incorporation of active moieties Injectability
Simple manufacturing and formulation Low mechan
drugs
pH Suitable for thermolabile drugs Lack of tox
Low mecha
Light Ease of controlling the trigger mechanism Low mechan
chromophAccurate control over the stimulus
Inconsistent
Electric ﬁeld Pulsative release with changes in electric
current
Surgical imp
Need of an
Difﬁculty in
Ultrasound Controllable protein release Specialized
Surgical imp
Mechanical
stress
Possibility to achieve the drug release Difﬁculty inwhich are inherently present in natural systems. Table 2 summarises
the various smart polymeric drug delivery systems.2. Stimuli-responsive polymers
A stimuli-sensitive or smart polymer undergoes an abrupt change
in its physical properties in response to a small environmental
stimulus. These polymers are also called as intelligent polymers
because small changes occurs in response to an external trigger
until a critical point is reached, and they have the ability to return
to their original shape after trigger is removed1–3. The exclusivity
of these polymers lies in their nonlinear response triggered by a
very small stimulus and which produces a noticeable macroscopic
alterations in their structure. Fig. 1 depicts various stimuli
responsible for controlling drug release from smart polymeric
drug delivery systems. These transitions are reversible and include
changes in physical state, shape and solubility, solvent interac-
tions, hydrophilic and lipophilic balances and conductivity. The
driving forces behind these transitions include neutralisation of
charged groups by the addition of oppositely charged polymers or
by pH shift, and change in the hydrophilic/lipophilic balance or
changes in hydrogen bonding due to increase or decrease in
temperature. The major beneﬁts of smart polymer-based drug
delivery systems includes reduced dosing frequency, ease of
preparation, maintenance of desired therapeutic concentration with
single dose, prolonged release of incorporated drug, reduced side
effects and improved stability4–6.
Responses of a smart polymeric solution can be of various
types. Responsiveness of a polymeric solution initiated by physical
or chemical stimuli is limited to the destruction and formation of
various secondary forces including hydrogen bonding, hydropho-
bic forces, van der Waals forces and electrostatic interaction7,8.
Chemical events include simple reactions such as oxidation, acid–
base reaction, reduction and hydrolysis of moieties attached to the
polymer chain. In some cases, dramatic conformational change in
the polymeric structure occurs, e.g., degradation of the polymeric
structure due to irreversible bond breakage in response to an
external stimulus. Critical attributes of a smart polymer should
include: biodegradability and biocompatibility; controlled releaseissues under application conditions.
ical strength, biocompatibility issues and instability of thermolablile
icity data
nical strength
ical strength of gel, chance of leaching out of noncovalently attached
ores
responses to light
lantation required
additional equipment for external application of stimulus
optimising the magnitude of electric current
equipment for controlling the release
lantation required for nonbiodegradable delivery system
controlling the release proﬁle
Figure 1 Various stimuli responsible for controlling drug release from smart polymeric drug delivery systems.
H. Priya James et al.122proﬁle; high drug loading capacity; lack of detrimental properties
such as systemic toxicity, immunogenicity, carcinogenicity and
reproductive toxicity, and an excellent stability proﬁle.3. Temperature-responsive polymers
Thermosensitive polymers undergo abrupt change in their solubility
in response to a small change in temperature. An aqueous thermo-
sensitive polymeric solution exhibits temperature-dependent and
reversible sol–gel transitions near body temperature that control the
rate of release of incorporated drug along with maintaining
physicochemical stability and biological activity. This phenomenon
is generally governed by the ratio of hydrophilic to lipophilic
moieties on the polymer chain and is an energy-driven phenomenon
which depends on the free energy of mixing or the enthalpy or
entropy of the system. A common characteristic feature of thermo-
sensitive polymers is the presence of hydrophobic group, such as
methyl, ethyl and propyl groups. These polymers possess two
additional critical parameters, i.e., lower critical solution tempera-
ture (LCST) and upper critical solution temperature (UCST)9–12.
Lower critical solution temperature is the temperature above which
the polymeric monophasic system becomes hydrophobic and
insoluble, leading to phase separation, whereas below the LCST
the polymers are soluble. For polymers having LCST, a small
increase in temperature results in negative free energy of the system
(ΔG) leading to a higher entropy term (ΔS) with respect to
increase in the enthalpy term (ΔH) in the thermodynamic relation
ΔG¼ΔHTΔS. The entropy increases due to water–water
associations. In contrast to UCST systems, an LCST system is
mostly preferred for drug delivery technologies due to the need for
high temperatures for UCST systems, which is unfavourable for
heat-labile drugs and biomolecules. According to the phase
response to the temperature change, polymers are subdivided into
negatively thermosensitive, positively thermosensitive, and ther-
moreversible types11. Examples of conformational change that
take place at the critical solution temperature are polymeric
micelle packing and coil-to-helix transitions. The most commonly
used LCST thermosensitive polymers include poly(N-isopropyl
acrylamide), poly(N,N-diethylacrylamide), poly(N-vinylalkylamide),
poly(N-vinylcaprolactam), phosphazene derivatives, pluronics,
tetronics, polysaccharide derivatives, chitosan and PLGA–PEG–
PLGA triblock copolymers11,13.
Poly(N-isopropyl acrylamide) is a thermosensitive polymer that
exhibits a sharp lower critical solution temperature at 32 1C that
can be shifted to body temperature by formulating with surfactants
or additives. These polymers exhibit unique characteristics with
respect to the sharpness of their almost discontinuous transition.This makes poly (NIPAAM) an excellent carrier for in situ drug
delivery. Gelation of 5% polymer solutions occurs at various
temperatures in phosphate-buffered saline (PBS). As the tempera-
ture is increased to 27 1C, the clear polymer solution became
cloudy and upon further heating the polymer solution forms a gel.
At the gel-shrinking temperature of 45 1C synaeresis, i.e., expul-
sion of water from the gel occurs. No hysteresis occurs between
sol–gel and gel–sol, it reverts to the sol state upon cooling to room
temperature. Use of poly NIPAAM is limited due to cytotoxicity
attributed to the presence of quaternary ammonium in its structure,
its non-biodegradability and its ability to activate platelets upon
contact with body ﬂuids.
Many attempts have been made to reduce the initial burst drug
release associated with thermosensitive systems due to slow
in vivo sol–gel transition. Studies proved that signiﬁcant improve-
ment in release characteristics can be achieved by optimising the
chain-length ratio between hydrophilic and hydrophobic segments.
A novel triblock polymeric system PCL-PEG-PCL showed a
marked reduction in initial burst release by coupling to a peptide
and in vitro drug release studies showed a sound sustained-release
proﬁle for over one month.
The major advantage of thermosensitive polymeric systems is the
avoidance of toxic organic solvents, the ability to deliver both
hydrophilic and lipophilic drugs, reduced systemic side effects, site-
speciﬁc drug delivery, and sustained release properties. In spite of
these advantages several drawbacks associated with these systems
include high-burst drug release, low mechanical strength of the gel
leading to potential dose-dumping, lack of biocompatibility of the
polymeric system and gradual lowering of pH of the system due to
acidic degradation14,15. Table 3 lists various applications of thermo-
sensitive polymers for drug delivery systems.4. pH-responsive polymers
All pH-sensitive polymers consist of pendant acidic or basic group
that can either accept or release a proton in response to changes in
environmental pH. Polymers with a large number of ionisable
groups are known as polyelectrolytes. Polyelectrolytes are classi-
ﬁed into two types: weak polyacids and weak polybases. Weak
polyacids accept protons at low pH and release protons at neutral
and high pH21. Poly(acrylic acid) (PAAc) and poly(methacrylica-
cid) (PMAAc) are commonly used pH-responsive polyacids22,23.
As the environmental pH changes, the pendant acidic group
undergoes ionisation at speciﬁc pH called as pKa. This rapid
change in net charge of the attached group causes alteration in the
molecular structure of the polymeric chain. This transition to
expanded state is mediated by the osmotic pressure exerted by
Table 3 Various applications of temperature-responsive polymeric drug delivery systems.
Drug Polymer Application Study goal/outcome Ref.
Docetaxel Conjugated linoleic acid
coupled with pluronic
F-127
Peritoneal
dissemination of
gastric cancer
Hydrogel produced controlled release
and excellent antitumour activity
16
Exenatide PLGA–PEG–PLGA Treatment of type II
diabetes
To produce a long-acting injectable
formulation
17
Ethosuximide Chitosan with
glycerophosphate
disodium salt and glycerol
Injectable gels for
depot therapy
To produce a sustained-release injectable
formulation
18
Human mesenchymal stem cells
and desferroxamine
Chitosan-beta
glycerophosphate
For the treatment of
critical limbic
ischaemia
To provide an in situ depot for the
sustained release of drugs and provide
protection and cohesion of stem cells
19
Leuprolide Polybenzofulvene For treatment of
tumours
To protect the oligopeptide drug and regulate the
release rate by external temperature
20
Table 4 Various applications of pH-responsive polymeric drug delivery systems.
Drug Polymer Application Study outcome Ref.
Paclitaxel and
dauxorubicin
Poly(ethylene glycol)-block-poly
(propylene glycol)-poly(ethylene glycol)
Prolongation of survival
time in comparison
with single drug
therapy
The release rate can be accelerated by
decreasing the environmental pH from
acidic to alkaline
25
Fibroblast
growth factor
Poly(n-isopropylacrylamide-co-
propylacrylic acid-co-butylacrylate)
To improve
angiogenesis in
infracted
myocardium
It provides the advantage of acidic
microenvironment of ischaemic
myocardium
26
Ketoprofen Poly(acrylamide)-g-carrageenan
and sodium alginate
For colon-targeted
delivery
Ketoprofen release was signiﬁcantly
increased when pH of the medium was
increased from acidic to alkaline
27
Dexamethasone Poly(methoxyl ethylene glycol-caprolactone-
co-methacrylic acid-co-poly(ethylene glycol)
methylethylenemethacrylate)
For oral drug delivery The hydrogel demonstrated a sharp
change at different pH values, with
suitability for oral drug delivery
28
Protein drug Alginate and chemically modiﬁed
carboxymethyl chitosan
For oral delivery Hydrogel protected the drug from the
harsh acidity of stomach with
potential release in the intestine
29
Polymers for the controlled delivery of drugs 123mobile counter ions neutralised by network charges. pH-Sensitive
polymers containing a sulphonamide group are another example of
polyacid polymers. These polymers have pKa values in the range
of 3–11 and the hydrogen atom of the amide nitrogen is readily
ionised to form polyacids. Narrow pH range and good sensitivity
is the major advantage of these polymers over carboxylic acid
based polymers.
Chitosan is a polycationic biopolymer soluble in acidic solution
and undergoes phase separation at a pH range close to neutrality
through deprotonation of the primary amino group by inorganic ions.
The gelation mechanism of chitosan occurs through the following
interactions which involve electrostatic attraction between the ammo-
nium group of the chitosan and an inorganic ion, hydrogen bonding
between the chitosan chains, and chitosan-chitosan hydrophobic
interactions. However, the formed gel is in further need of cross
linking agents to produce a gel with sufﬁcient mechanical stability and
to release the low molecular weight drug in a controlled manner.
Several studies reported that the structural strength of chitosan depends
on the porosity of the chitosan gel which in turn is a function of the
crystallinity of the polymer. The structural strength of the polymer
can be improved either by blending with the polymers or by
hydrophobic modiﬁcation of the polymer. One example includes the
cross linking of chitosan – polyvinylpyrrolidine with gluteraldehyde toform a semi-interpenetrating polymeric network that gells in situ at
physiological pH.
Polybases bearing an attached amino group are the most
representative polybasic group. Poly(N,N-dimethylaminoethyl-
methacrylate) (PDMAEMA) and poly(N,N-diethylaminoethyl-
methacrylate) (PDEAEMA) have been the most frequently used
pH-responsive polymeric bases. The amino group is protonated at
high pH and positively neutralised and ionised at low pH.
PDEAEMA has a hypercoiled conformation because the presence
of longer hydrophobic groups such as ethyl groups, which induce
stronger hydrophobic interactions as the aggregation force. Intro-
ducing a more hydrophobic moiety can offer a more compact
conformation and a more discontinuous phase. Poly(4 or 2-
vinylpyrrolidine) (PVP), poly(vinyl-immidazole) (PVI) and quar-
tinized poly(propyleneimine) have also been explored for use in
drug delivery24. Table 4 lists various applications of pH-
responsive polymers for drug delivery systems.5. Bioresponsive polymers
Biologically responsive polymer systems are increasingly impor-
tant in various biomedical applications. The major advantage of
H. Priya James et al.124bioresponsive polymers is that they can respond to the stimuli that
are inherently present in the natural system. Bioresponsive
polymeric systems mainly arise from common functional groups
that are known to interact with biologically relevant species, and in
other instances the synthetic polymer is conjugated to a biological
component. Bioresponsive polymers are classiﬁed into antigen-
responsive polymers, glucose-sensitive polymers, and enzyme-
responsive polymers.5.1. Glucose-reponsive polymers
Glucose responsive polymers have the ability to mimic normal
endogenous insulin secretion which minimises diabetic complica-
tions and can release the bioactive compound in a controlled
manner. These are sugar-sensitive and show variability in response
to the presence of glucose. These polymers have garnered
considerable attention because of their application in both
glucose-sensing and insulin-delivery applications. In spite of these
advantages, the major limitations are its short response time and
possible non-biocompatibility. Glucose-responsive polymeric-
based systems have been developed based on the following
approaches: enzymatic oxidation of glucose by glucose oxidase,
and binding of glucose with lectin or reversible covalent bond
formation with phenylboronic acid moieties.
Glucose sensitivity occurs by the response of the polymer
toward the byproducts that result from the enzymatic oxidation of
glucose. Glucose oxidase oxidises glucose resulting in the forma-
tion of gluconic acid and H2O2. For example, in the case of poly
(acrylicacid) conjugated with the GOx system, as the blood
glucose level is increased glucose is converted into gluconic acid
which causes the reduction of pH and protonation of PAA
carboxylate moieties, facilitating the release of insulin. This
system is increasingly successful due to its release pattern
mimicking that of the endogenous release of insulin30,31.
Another system utilises the unique carbohydrate binding
properties of lectin for the fabrication of a glucose-sensitive
system. Lectins are multivalent proteins and numerous glucose-
responsive materials are obtained from this glucose-biding prop-
erty of lectins. The response of these systems was speciﬁc for
glucose and mannose, while other sugars caused no response.
Concanavalin A (Con A) is a lectin possessing four binding sites
and has been used frequently in insulin-modulated drug delivery.
In this type of system the insulin moiety is chemically modiﬁed by
introducing a functional group (or glucose molecule) and then
attached to a carrier or support through speciﬁc interactions which
can only be interrupted by the glucose itself. The glycosylated
insulin-Con A complex exploits the competitive binding behaviour
of Con A with glucose and glycosylated insulin. The free glucoseTable 5 Applications of glucose-responsive drug delivery systems.
Polymer Application Study outcome
Methacrylate derivatives
of dextran and concanavellin
Self-regulated insulin
delivery
The results sugg
different gluco
N-(2-(dimethylamino) ethyl)-
methacrylamide) and
concanavelin A
For the controlled
release of insulin
The microhydro
concentration
N,N-(dimethylacrylamide) and
sulfadimethoxine monomer
Sulphonamide-based
glucose-responsive
hydrogel
The hydrogel sho
between 0 andmolecule causes the displacement of glycosylated Con A-insulin
conjugates within the surrounding tissues and are bioactive.
Additional studies reported the synthesis of monosubstituted
conjugates of glucosyl-terminal PEG and insulin. The G-PEG–
insulin conjugates were covalently bound to Con A that was
attached to a PEG–poly(vinylpyrrolidine-co-acrylicacid) back-
bone, and as the concentration of glucose increased competitive
binding of glucose to Con A led to displacement and release of
G-PEG insulin conjugates32.
Other approach includes polymers with phenylboronic groups
and polyol polymers that form a gel through complex formation
between the pendant phenylborate and hydroxyl groups33. Instead
of polyol polymers, short molecules such as diglucosylhexadia-
mine have been used. As the glucose concentration increases, the
crosslinking density of the gel decreases and as a result insulin is
released from the eroded gel. The glucose exchange reaction is
reversible and reformation of the gel occurs as a result of borate–
polyol crosslinking. The major limitation of this system is the low
speciﬁcity of PBA-containing polymers. Table 5 lists various
applications of smart polymers in glucose-sensitive drug delivery
systems.6. Field-responsive polymers
Field-responsive polymers respond to the application of electric,
magnetic, sonic or electromagnetic ﬁelds. The additional beneﬁt
over traditional stimuli-sensitive polymers is their fast response
time, anisotropic deformation due to directional stimuli, and also a
controlled drug release rate simply by modulating the point of
signal control.
6.1. Light-sensitive polymers
A light-sensitive polymer undergoes a phase transition in response
to exposure to light. The major advantages of light-sensitive
polymers are that they are water soluble, biocompatible and
biodegradable. Another one is their capacity for instantaneous
delivery of the sol–gel stimulus, making light-responsive polymers
important for various engineering and biomedical applications.
Light-responsive polymers are very attractive for triggering drug
release because of the ability to control the spatial and temporal
triggering of the release. This means that the encapsulated drug
can be released or active after irradiation with a light source from
outside the body. Limitations of light-sensitive polymers include
inconsistent response due to the leaching of noncovalently-bound
chromophores during swelling or contraction of the system, and a
slow response of hydrogel towards the stimulus. Dark toxicity is
also one of the drawbacks of light-responsive polymeric systems.Ref.
ested that insulin release was reversible in response to
se concentrations and the released insulin was active
34
gels could quickly respond to changes in glucose
in the medium and a small change in the microenvironment
35
wed reversible swelling as a function of glucose concentration
300 mg/dL in buffered saline solution at pH 7.4
36
Polymers for the controlled delivery of drugs 125These polymers can be classiﬁed into UV-sensitive and visible-
sensitive systems on the basis of the wavelength of light that
triggers the phase transition. Visible light-sensitive polymers are
comparatively preferred over UV-sensitive polymers because of
their availability, safety and ease of use11,37.
Polymer gels containing a leuco-derivative molecule, bis(4-
dimethylamino)phenylmethyl leucocyanide, undergo phase transi-
tion behaviour in response to UV light. Triphenylmethane-leuco
derivatives dissociate into ion-pairs such as triphenylmethyl
cations upon UV irradiation. At a ﬁxed temperature these
hydrogels swell discontinuously due to increased osmotic pressure
in response to UV irradiation but shrink when the stimulus is
removed. Increased osmotic pressure within the gel was due to the
appearance of cyanide ions formed by UV irradiation.
Lee et al.38 developed a new photo-polymerized hydrogel to
overcome the problem of a long induction period during photo-
polymerisation. The system consists of a thermosensitive diary-
lated pluronic F-127 solution which is subjected to UV irradiation
before injection into the target site. After injection, the system can
offer the formation of a stable hydrogel, reducing the damage to
normal tissue around the injection site due to direct UV exposure
and eliminate the requirement for equipment for UV cross-linking
after injection. Although sustained release is achieved, the
common problems inherent in this system include high initial
burst release, rapid release rate, toxicity of unreacted monomers,
low penetration depth of irradiated light, long induction periods,
and the need to use photosensitive initiators at high concentration.
Visible light-sensitive hydrogels are prepared by incorporating
photosensitive molecules such as chromophores (e.g., trisodium
salt of copper chlorophyllin). When light of appropriate wave-
length is applied, the chromophore absorbs light which is then
dissipated locally as heat by radiationless transition, increasing the
local temperature of the hydrogel, leading to alteration of the
swelling behaviour of thermosensitive hydrogel. The temperature
increase directly depends on the chromophore concentration and
light intensity. The potential application of visible light-responsive
hydrogels for temporal drug delivery is mainly based on the
response of cross linked hyalouronic acid hydrogel that undergoes
photosensitized degradation in the presence of methylene blue.
Another activation mechanism is the use of infrared light which
can elicit a response in hydrogels in the absence of chromophores.
The major advantage of this method is due to the high infrared
light absorbency of water. When hydrogels without chromophores
are irradiated by CO2 infrared laser the volume phase transition
along with gel bending towards the laser beam was observed,
while the relaxation of the gel to its original form after irradiation
was terminated followed34,39.6.2. Electric ﬁeld-sensitive polymers
Electric ﬁeld-sensitive polymers change their physical properties in
response to a small change in electric current. These polymers
contain a relatively large concentration of ionisable groups along
the back bone chain and they are pH-responsive as well. Electro-
responsive polymers transform electric energy into mechanical
energy and they have wide application in the ﬁeld of controlled
drug delivery, artiﬁcial muscle actuations, energy transductions
and sound dampening. The electric current causes a change in pH
which leads to disruption of hydrogen bonding between polymer
chains, causing degradation or bending of the polymer chain
leading to drug release. Major mechanisms involved in drugrelease from electro-responsive polymer are diffusion, electro-
phoresis of charged drug, forced convection of drug out of the gel
along with syneresed water and liberation of drug upon erosion of
electro-erodible polymers. Gel bending due to electric ﬁeld stimulus
depends on a number of factors such as variable osmotic pressure,
position of the gel relative to the electrodes, thickness or shape of
the gel and the applied voltage. The major constraint that has to be
considered in this type of drug delivery system is the critical
selection of electric current which can cause drug release without
stimulating the nerve endings in the surrounding tissue40,41.
Naturally occurring polymers such as chitosan, alginate and
hyalouronic acid are commonly employed to prepare electro-
responsive materials. Major synthetic polymers that have been
used include allyl amine, vinyl alcohol, acrylonitrile, methacrylic
acid and vinylacrylic acid. In some cases, combinations of natural
and synthetic polymers have been used. Most polymers that
exhibit electro-sensitive behaviour are polyelectrolytes and they
undergo deformation under an electric ﬁeld due to anisotropic
swelling or deswelling as the charged ions move towards the
cathode or anode. Greatest stress is felt by the region surrounding
the anode and smaller stress near the vicinity of the cathode. This
stress gradient contributes to the anisotropic gel deformation under
an electric ﬁeld42,43.
Neutral polymers that exhibit electro-sensitive behaviour
require the presence of a polarisable component with the ability
to respond to the electric ﬁeld. A rapid bending of gel in silicon oil
was observed in the case of lightly cross-linked poly(dimethylsi-
loxane)-containing electrosensitive colloidal SiO2 particles.
One of the applications of electrosensitive polymers includes
the delivery of edrophonium hydrochloride and hydrocortisone in
a pulsatile manner using the polymer poly(2-acrylamido-2-methyl-
propane sulphonic acid-co-n-butylmethacrylate)44. Control of drug
release was achieved by varying the intensity of electric stimula-
tion in distilled deionized water. For a positively charged drug, the
release pattern depends on ion exchange between hydrogen ion
produced by electrolysis of water and positively charged solute.7. Future challenges for drug delivery systems encompassing
stimuli-responsive polymers
Most of the currently developed smart polymeric drug delivery
systems and their applications have not yet made the clinical
transition. In such a case, there are some critical points that have to
be considered. The most signiﬁcant one is the potential cytotoxi-
city of smart polymers involved in the delivery of biomolecular
drugs, such as peptides, proteins and nucleic acid drugs. Another
reason is the response time of the polymer; in majority of cases, it
occurs on a reasonably slow time, and therefore fast-acting
polymer systems are required. Thermoresponsive polymeric drug
delivery systems are well characterized and have proven useful for
a wide range of applications. Unfortunately, most commonly used
acrylamide or acrylic acid polymers are not hydrolytically degrad-
able and often are associated with neurotoxicity. So these adverse
effects limit the ﬁeld of smart polymeric drug delivery.
Higher molecular weight smart polymers are more effective in
reaching their cellular targets, but they are not biodegradable and
not excreted, so they tend to accumulate in the body. This may be
why they have not been tested in clinical trials. Research into
smart drug delivery systems is predominantly focussed on cancer
treatment and has attractive features such as physical or active
targeting towards cancer cells and special protection of drug under
H. Priya James et al.126circulation. But these do not show any clinical success until the
drug delivery system can kill every last cancer cell. Some cancer
cells undergo metastasis and are very difﬁcult to kill. This
challenging behaviour of cancer cells represents a huge barrier
to the clinical use of smart polymers.
Smart polymeric drug delivery systems have wide applications
in the ﬁeld of oral drug delivery of biological drugs which are
sensitive to both gastric acid and enteric enzymes. Another
application is in the ﬁeld of smart diagnostics, since their use
does not normally involve direct contact with the body. This is an
area where smart polymeric drug delivery system should even-
tually be very successful.8. Conclusions
With the advancement of novel drug delivery systems, smart
polymeric drug delivery systems provide a link between therapeutic
need and drug delivery. This review highlights the current literature
and describes the principles and mechanisms of smart materials.
Various stimuli are utilized to attain the controlled and site-speciﬁc
delivery of drug. Inherent limitations of this drug delivery system
are slow response times. While there are many exciting challenges
facing this ﬁeld, there are a number of opportunities for the
development of smart polymeric drug delivery systems. Smart
polymeric drug delivery systems have a very wide range of
applications and are likely to have an exciting future.References
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